NEGOTIATED PROCEDURE, PURSUANT TO ART. 76 OF LEGISLATIVE DECREE NO. 36/2023, FOR THE SUPPLY OF THE DRUG SKYCLARYS 200MG REQUIRED BY ASL ROMA 4 – YEAR 2025.

This tender concerns a negotiated procedure, conducted without prior publication of a call for tenders, as per Article 76 of Legislative Decree No. 36/2023. The contracting authority, ASL Roma 4, sought the supply of the pharmaceutical product SKYCLARYS 200mg for its requirements in the year 2025. The procurement falls under the category of 'Various Medicinal Products' (CPV: Medicinali vari) and is classified as a supply contract. The procedure was initiated by ASL Roma 4, located in Civitavecchia, Rome. The estimated value of the contract was set at EUR 980,000.00. Following the procedure, the contract was awarded to BIOGEN ITALIA S.R.L. for a final value of EUR 976,854.60. This specific drug, SKYCLARYS 200mg, is the subject of this procurement, indicating a targeted need for this particular medication within the healthcare services provided by ASL Roma 4. The negotiated procedure, without prior advertisement, suggests that the authority may have identified specific circumstances or a limited number of potential suppliers, allowing for a more direct negotiation process to fulfill this essential medical supply requirement for the upcoming year.

This is a supplies contract in the general supplies sector. Located in Italy, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 980,000.

Published through ANAC (Italy), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the general supplies sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.